Constant check-ins: Were with you every step of the way, making sure youre safe and seeing results
The study reported a significant improvement in the resolution of MASH, with 39% of patients achieving this outcome as compared to 9% in the placebo group
The FDA has issued a black box warning about the risks associated with abrupt discontinuation, which can lead to worsening angina, increased chest pain, or even a heart attack
INJECTABLE MENU WELLNESS MENU Wellness services designed to restore balance, boost energy, and improve your overall quality of life from the inside out
While there are no absolute dietary restrictions, certain dietary approaches may help minimize side effects
FDA approves Wegovy for MASH with moderate to advanced liver fibrosis owenhaskins Aug 18, 2025 2 min read The FDA has approved Wegovy (semaglutide) injection 2.4 mg to treat adults with MASH with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver, in conjunction with a reduced calorie diet and increased physical activity
